266 Second Ave., Waltham, MA 266 Second Ave. in Waltham, MA will be the new home for fledgling biopharmaceutical company ImmuneXcite.
WALTHAM, MA—The robust biotech-biopharmaceutical market in Greater Boston continues to churn out deals. ImmuneXcite has signed a more than 10,000-square-foot lease for newly converted lab space at 266 Second Ave. here. The Lexington, MA-based biopharmaceutical company that is focused on developing transformative immuno-oncology products, signed a lease for 10,323 square feet at the property owned by an affiliate of Rockwood Capital LLC . John Edwards , executive chairman of ImmuneXcite, tells Globest.com the company will relocate its headquarters and lab operations from Lexington (3 Forbes Road) to the Waltham building. The company, which reported in late March that it secured $8.6 million in Series A-1 financing, currently has 10 employees. The company expects to take occupancy of its new headquarters later this year. 266 Second Ave. is a two-story 95,808-squqre-foot building that is part of a two-building complex. Transwestern RBJ represented both tenant and landlord in the lease deal. The brokerage firm’s Jon Varholak , Rob Byrne and Perry Beal represented the building ownership, while Bob Richards represented ImmuneXcite in the transaction. Building ownership, in conjunction with property manager, Griffith Properties LLC , recently completed what it terms was a “significant capital campaign” to convert the building’s second floor from office to laboratory space to meet demand in Greater Boston’s life sciences market. The ownership is in the process of building out an 11,000-square-foot speculative suite for delivery in third-quarter 2016. NetBio occupies the building’s first-floor lab space. “Rockwood and Griffith made a tremendous strategic move in converting 266 Second Ave. to full laboratory use,” states Varholak. “The building offers a high-quality suburban alternative for companies seeking lab space in the increasingly tight Cambridge market, while still being in close proximity to the city. It’s an excellent location for a dynamic, young life sciences company like ImmuneXcite, which is currently located in Lexington.” Waltham had 998,000 square feet of laboratory space with a 5.4% vacancy rate at the close of first-quarter 2016. For the same period, Greater Boston’s suburbs had 5.6 million square feet of laboratory space with a 10.4% vacancy rate, according to Transwestern

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.